Search Results - "Panchenko, Iu. O."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Role of polymorphisms of folate-cycle enzymes in diabetic retinopathy progression in patients with type 2 diabetic mellitus by Rykov, S. O., Prokopenko, Iu. V., Natrus, L. V., Panchenko, Iu. O.

    Published in Oftalmologicheskiĭ zhurnal. (26-10-2022)
    “…Background: Hyperhomocysteinemia is important in the development of endothelial dysfunction, a pathogenetic component of diabetic retinopathy (DR) in type 2…”
    Get full text
    Journal Article
  2. 2

    Predicting DME recurrence following surgical treatment for diabetic maculopathy in a Ukrainian population of patients with type 2 diabetes mellitus by Panchenko, Iu. O., Mogilevskyy, S.Yu, Rykov, S.O., Zhaboiedov, D.G., Umanets, M.M., Ziablitsev, S.V.

    Published in Oftalmologicheskiĭ zhurnal. (01-08-2021)
    “…Background: Recurrent diabetic maculopathy (DMP) and diabetic macular edema (DME) may develop in the early or late period even after an advanced vitreoretinal…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Levels of neuroinflammation markers in type 2 diabetes mellitus patients with diabetic retinopathy and genetically determined hyperhomocysteinemia by Iu. O. Panchenko, V. S. Tsybulskyi, L. V. Natrus, H. Ie. Zakharevych

    Published in Oftalmologicheskiĭ zhurnal. (01-08-2024)
    “…Background: Hyperhomocysteinemia determined by polymorphisms of genes encoding folate cycle enzymes is closely correlated with markers of systemic…”
    Get full text
    Journal Article
  5. 5

    CONNECTION OF PDGFB GENE POLYMORPHISM rs1800818 WITH SURGICAL TREATMENT RELAPSES OF DIABETIC MACULOPATHIA IN TYPE 2 DIABETES MELLITUS by Panchenko, Iu. O.

    Published in Visnyk problem biolohiï i medyt︠s︡yny (01-11-2019)
    “…In diabetic eyes lesions, the importance of the Platelet-Derived Growth Factor (PDGF-BB), its genes and receptors has been shown. Aim of this study: to…”
    Get full text
    Journal Article
  6. 6

    New risk factors for post-surgical recurrent diabetic maculopathy in type 2 diabetes mellitus by Mogilevskyy, S., Panchenko, Iu, Ziablitsev, S.

    Published in Oftalmologicheskiĭ zhurnal. (01-11-2019)
    “…Background: Some pathogenetic risk factors (platelet-derived growth factor (PDGF); tumor necrosis factor alpha (TNF?); and Endothelin-1 (ET1)) are involved in…”
    Get full text
    Journal Article
  7. 7

    Predicting the risk of diabetic retinopathy-associated macular edema in patients with type 2 diabetes mellitus by Mogilevskyy, S., Panchenko, Iu, Ziablitsev, S.

    Published in Oftalmologicheskiĭ zhurnal. (05-06-2019)
    “…Background: Previously, we have reported on the value of prothrombotic platelet phenotype as a factor for the development of diabetic maculopathy (DMP) and…”
    Get full text
    Journal Article
  8. 8

    Influence of local and systemic factors of type 2 diabetes mellitus on the functional status of platelets in patients with diabetic retinopathy and maculopathy by Mogilevskyy, S., Panchenko, Yu, Ziablitsev, S., Ziablitsev, D.

    Published in Oftalmologicheskiĭ zhurnal. (28-12-2018)
    “…Background: To date, there is no information on relationships of systemic (activation of the sympathoadrenal and renin- angiotensin systems, SAS and RAS,…”
    Get full text
    Journal Article